Is axillary dissection needed in node-positive breast cancer?
CC Greenberg, AC Bafford… - Expert Review of …, 2008 - Taylor & Francis
The standard of care in the management of the axilla for a woman with breast cancer was
traditionally a level I and II axillary lymph node dissection (ALND). Since the pivotal studies …
traditionally a level I and II axillary lymph node dissection (ALND). Since the pivotal studies …
Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging
KA Vanderveen, PD Schneider, VP Khatri… - Annals of surgical …, 2006 - Springer
Background Sentinel lymph node biopsy (SLNB) has become a standard for axillary staging
for early breast cancer patients. Prior studies suggest that SLNB may be more sensitive for …
for early breast cancer patients. Prior studies suggest that SLNB may be more sensitive for …
Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?
B Gerber, K Heintze, J Stubert, M Dieterich… - Breast cancer research …, 2011 - Springer
Abstract Evaluation of axillary lymph node status by sentinel lymph node biopsy (SLNB) and
complete axillary lymph node dissection (ALND) are an inherent part of breast cancer …
complete axillary lymph node dissection (ALND) are an inherent part of breast cancer …
Preoperative and intraoperative lymphatic mapping for radioguided sentinel lymph node biopsy in breast cancer
LM Pereira Arias-Bouda, S Vidal-Sicart… - … and Sentinel Node …, 2020 - Springer
The axillary lymph node status remains a major prognostic factor in early-stage breast
cancer, providing information that is important for tailoring postsurgical treatment. Sentinel …
cancer, providing information that is important for tailoring postsurgical treatment. Sentinel …
Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall …
F Ebner, A Wöckel, W Janni, R Kreienberg… - Journal of Cancer …, 2017 - Springer
Purpose Sentinel lymph node (SLN) biopsy has replaced axillary lymph node dissection
(ALND) for the staging of clinically node-negative breast cancer patients (BCP) …
(ALND) for the staging of clinically node-negative breast cancer patients (BCP) …
Omitting SLNB in breast cancer: is a nomogram the answer?
AM Moorman, EJT Rutgers… - Annals of Surgical …, 2022 - Springer
Backgrounds Sentinel lymph node biopsy (SLNB) is standard care as a staging procedure in
patients with invasive breast cancer. The axillary recurrence rate, even after positive SLNB …
patients with invasive breast cancer. The axillary recurrence rate, even after positive SLNB …
Axillary lymph node burden in invasive breast cancer: a comparison of the predictive value of ultrasound-guided needle biopsy and sentinel lymph node biopsy
BA Boone, C Huynh, ML Spangler, J Sumkin… - Clinical breast …, 2015 - Elsevier
Background Recent studies suggest that axillary lymph node dissection (ALND) may be
omitted in select breast cancer patients with a positive sentinel lymph node biopsy (SLNB) …
omitted in select breast cancer patients with a positive sentinel lymph node biopsy (SLNB) …
[HTML][HTML] Improved false negative rate of axillary status using sentinel lymph node biopsy and ultrasound-suspicious lymph node sampling in patients with early breast …
Y Wang, H Dong, H Wu, L Zhang, K Yuan, H Chen… - BMC cancer, 2015 - Springer
Background The false negative rate of sentinel lymph node biopsy (SLNB) is 5-10%, and
results in improper patient management. The study was to assess the value of ultrasound …
results in improper patient management. The study was to assess the value of ultrasound …
Considerations for sentinel lymph node biopsy in breast cancer patients with biopsy proven axillary disease prior to neoadjuvant treatment
Background Axillary disease can be downstaged with neoadjuvant treatment for breast
cancer. We attempted to identify factors to consider in determining whether to perform a …
cancer. We attempted to identify factors to consider in determining whether to perform a …
Selective or routine axillary disease staging for patients with clinically lymph node–negative breast cancer?
TJ Hieken, JM Velasco - Surgery, 2006 - Elsevier
BACKGROUND: Although sentinel lymph node biopsy (SLNB) has become the standard for
patients with clinically lymph node–negative breast cancer, less than one third of patients …
patients with clinically lymph node–negative breast cancer, less than one third of patients …